The liver X receptor: control of cellular lipid homeostasis and beyond Implications for drug design

Maaike H Oosterveer1, Aldo Grefhorst, Albert K Groen

  • 1Department of Pediatrics, Center for Liver Digestive and Metabolic Diseases, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. m.h.oosterveer@med.umcg.nl

Insights

Liver X receptors (LXRs) regulate metabolism and show promise for treating atherosclerosis and diabetes. However, side effects like fatty liver necessitate targeted therapies for safe clinical use.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Liver X receptors (LXRs) α and β are nuclear receptors crucial for regulating cellular cholesterol and lipid metabolism.
  • LXRs respond to cellular cholesterol levels, making them key targets for treating metabolic diseases like atherosclerosis.
  • Previous studies in rodents show LXR agonists can halt atherosclerosis but cause adverse effects like hepatic steatosis.

Purpose of the Study:

  • To explore the multifaceted roles of LXRs beyond cholesterol homeostasis, including implications for obesity, Alzheimer's disease, and type 2 diabetes.
  • To identify strategies for developing novel LXR agonists that maximize therapeutic benefits while minimizing adverse effects.
  • To establish tissue- and isotype-specific effects of LXR action for targeted therapeutic development.

Main Methods:

  • Review of existing literature on LXR function and pharmacological activation.
  • Analysis of LXR's role in cholesterol efflux, transport, and excretion in preclinical models.
  • Investigation of LXR's impact on hepatic lipid metabolism, glucose control, and other physiological processes.

Main Results:

  • LXR activation effectively promotes cholesterol efflux and halts atherosclerosis progression in rodents.
  • Pharmacological LXR activation can lead to undesirable hepatic steatosis and increased secretion of atherogenic VLDL particles.
  • Emerging evidence suggests LXRs play roles in fat tissue, pituitary, and brain, with potential therapeutic implications for obesity and Alzheimer's disease.
  • LXR activation demonstrates beneficial effects on glucose control in mouse models of type 2 diabetes.

Conclusions:

  • Targeting specific LXR-mediated processes is essential for developing effective therapies for metabolic diseases.
  • Understanding tissue- and isotype-specific LXR actions is critical for circumventing adverse effects.
  • Combinatorial drug approaches and identification of co-regulatory networks can lead to novel LXR agonists with improved therapeutic profiles.
  • Pathway analyses of LXR actions offer valuable tools for optimizing novel therapeutic strategies for metabolic disorders.

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Liver Physiology01:30

Liver Physiology

The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of  70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...